Dr. Roberto Bolli, MD

Dr. Bolli practices at Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky.

Dr. Bolli's NPI, 1306846696, was assigned on July 28, 2005. Dr. Bolli holds Kentucky license 31035.

Dr. Bolli's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD, at 200 Abraham Flexner Way, Louisville, KY 40202.

Dr. Bolli's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky. Dr. Bolli is also affiliated with UofL Health - Jewish Hospital. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Bolli to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bolli practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bolli's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bolli is licensed in Kentucky.

CMS data shows 749 Medicare services from Dr. Bolli across 4 procedure codes in 2024, for 437 Medicare patients. Medicare paid $9,789 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 437 Medicare patients who saw Dr. Bolli in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bolli's median patient age at 70, with 44% women.

In 2024, Dr. Bolli wrote 45 Medicare Part D claims for 16 patients. 93% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $119 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Bolli for performance year 2024, reported as part of a group. Dr. Bolli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 162 papers to Dr. Bolli, published from 2007 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Myocardial Infarction, Myocytes, Cardiac and Myocardium. Dr. Bolli has published most often in Circ Res. Dr. Bolli's most frequent co-authors are Joshua M. Hare, FACC, MD, Timothy D. Henry, MD and Jay H. Traverse, MD.

Dmand AI links Dr. Bolli to 3 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Cardiomyopathies, Ventricular Dysfunction, Left and Sarcoma. The University of Texas Health Science Center, Houston sponsors the most, 2.

CMS Open Payments shows 9 general payments to Dr. Bolli from 2 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $154.